The Biomedical Advanced Research and Development Authority (BARDA) will begin procuring Emergent BioSolutions’ anthrax vaccine into the Strategic National Stockpile (SNS) to strengthen U.S. preparedness in the event of a public health threat, the company said on Wednesday.
{iframe}https://homelandprepnews.com/stories/33929-barda-will-procure-emergent-biosolutions-av7909-anthrax-vaccine-in-strategic-national-stockpile/{/iframe}